Recently Viewed
empty-cart

There are no Recent Items

Close
Login/Register

Close
Single User License Price USD 3000
Single User License Price INR 213600
Hard Copy License Price USD 3100
Hard Copy License Price INR 220720
Corporate User License Price USD 5000
Corporate User License Price INR 356000
Request a Quote

Report Title

Global Mycophenolate Mofetil Market Outlook 2017-2022

Quote Request for License Type
License Type Price  
Single User License USD 3000
Hard Copy License USD 3100
Enterprise Wide License USD 5000
"Thanks for submitting the form. Our marketing team will connect back to you for the budget constraint."
Close
REQUEST A CUSTOMIZED RESEARCH

Report Title

Global Mycophenolate Mofetil Market Outlook 2017-2022


Quote Request for License Type
License Type Price  
Single User License USD 3000
Hard Copy License USD 3100
"Thanks for letting us know your requirement. Our research team will connect back to you for the bespoke requirement."
Close
REQUEST FOR SAMPLE REPORT

Report Title

Global Mycophenolate Mofetil Market Outlook 2017-2022

"Thanks for submitting the form. The concerned team will send the sample report in the next 12 hours."
"Thank you for downloading the sample report."
Close

Global Mycophenolate Mofetil Market Outlook 2017-2022



Executive Summary

Mycophenolate mofetil is a prodrug of mycophenolic acid (MPA), an inhibitor of inosine monophosphate dehydrogenase (IMPDH). Mycophenolate mofetil is marketed under the trade name CellCept and mycophenolate sodium as Myfortic.

The five-year forecast for the mycophenolate mofetil market shows a healthy Compound Annual Growth Rate (CAGR) of 5.3 percent driven by increased demand, according to a new report published by Gen Consulting Company.

The report covers forecast and analysis for the mycophenolate mofetil market on a global and regional level. The study provides historic data of 2012-2016 along with a forecast from 2017 to 2022 based on both output/volume and revenue. The study then describes the drivers and restraints for the mycophenolate mofetil market along with the impact they have on the demand over the forecast period. Additionally, the report includes the study of opportunities available in the mycophenolate mofetil market on a global level.

The report has been prepared based on the synthesis, analysis, and interpretation of information about the global mycophenolate mofetil market collected from specialized sources. The competitive landscape section of the report provides a clear insight into the market share analysis of key industry players. Company overview, financial overview, product portfolio, new project launched, recent development analysis are the parameters included in the profile.

On the basis of products, the market for mycophenolate mofetil is segmented into Capsule, Tablet, Injection, others. All the segments have been analyzed based on present and future trends and the market is estimated from 2017 to 2022. Relevantly, the report and company profiles specify the key drivers that are impacting the demand in global mycophenolate mofetil market.

Key Product Types

Capsule

Tablet

Injection

Key Regions

North America

Europe

Asia Pacific

Middle East and Africa

South America

Key Vendors

Apotex

Arevipharma

Baiqi

Biocon

CCSB

Concord Biotech

Excella Gmbh

Formosa

Huadong Medicine

Hubei Teyer

Hunan Warrant

Livzon

Lunan

NCPC

PKU Healthcare

Roche Pharma

RPG Life Sciences

request free sample to get a complete list of companies

Key Questions Answered in this Report

What will the market size be in 2022?

What are the key factors driving the global mycophenolate mofetil market?

What are the challenges to market growth?

Who are the key players in the mycophenolate mofetil market?

What are the market opportunities and threats faced by the key players?

Part 1. Exclusive Summary

Part 2. Methodology

2.1 Research Methodology

2.2 Geographic Scope

2.3 Years Considered

Part 3. Introduction

3.1 Product Overview

3.2 Mechanisms of Action

3.3 Manufacturing Process

3.3.1 Raw Materials

3.3.2 Cost Analysis

Part 4. Competitive Landscape

4.1 Global Mycophenolate Mofetil Market, by Volume 2012-2017

4.1.1 Overview

4.1.2 Global Mycophenolate Mofetil Market, by Volume, by Company

4.1.3 Top 10 Companies by Volume Share

4.2 Global Mycophenolate Mofetil Market, by Revenue 2012-2017

4.2.1 Overview

4.2.2 Global Mycophenolate Mofetil Market, by Revenue, by Company

4.2.3 Top 10 Companies by Revenue Share

Part 5. Market Dynamics

5.1 Market Drivers

5.2 Challenges

Part 6. Segmentation by Application

6.1 Overview

6.2 Capsule

6.3 Tablet

6.4 Injection

Part 7. API Supply by Region

7.1 Global Mycophenolate Mofetil Volume by Region

7.1.1 North America

7.1.2 Europe

7.1.3 Asia-Pacific

7.2 Global Mycophenolate Mofetil Revenue by Region

7.2.1 North America

7.2.2 Europe

7.2.3 Asia-Pacific

Part 8. Consumption Pattern

8.1 North America

8.1.1 Overview

8.1.2 by Application

8.1.3 by Country (U.S., Canada, Mexico, etc.)

8.2 Europe

8.2.1 Overview

8.2.2 by Application

8.2.3 by Country (Germany, UK, France, Spain, Italy, etc.)

8.3 Asia-Pacific

8.3.1 Overview

8.3.2 by Application

8.3.3 by Country (China, Japan, Korea, India, etc.)

8.4 MEA

8.4.1 Overview

8.4.2 by Application

8.4.3 by Country (Saudi Arabia, Turkey, Nigeria, Iran, South Africa, etc.)

8.5 South America

8.5.1 Overview

8.5.2 by Application

8.5.3 by Country (Brazil, Argentina, Colombia, etc.)

Part 9. Mycophenolate Mofetil Market Forecast

9.1 Global Mycophenolate Mofetil Market Size 2017-2022

9.2 Global Mycophenolate Mofetil Market by Region 2017-2022

9.2.1 North America

9.2.2 Europe

9.2.3 Asia-Pacific

9.3 Global Mycophenolate Mofetil Consumption 2017-2022

9.4 Global Mycophenolate Mofetil Market by Application 2017-2022

Part 10. Company Profiles

10.1 Apotex

10.1.1 Business Overview

10.1.2 Products Offered

10.1.3 Financials

10.2 Arevipharma

10.3 Baiqi

10.4 Biocon

10.5 CCSB

10.6 Concord Biotech

10.7 Excella Gmbh

10.8 Formosa

10.9 Huadong Medicine

10.10 Hubei Teyer

10.11 Hunan Warrant

10.12 Livzon

10.13 Lunan

10.14 NCPC

10.15 PKU Healthcare

10.16 Roche Pharma

10.17 RPG Life Sciences

...

Part 11. Industry Activity

11.1 M&As, JVs and Partnership

11.2 Other Developments

Part 12. Appendix

12.1 Abbreviations

12.2 Disclaimer

To know more information on Purchase by Section, please send a mail to sales@kenresearch.com


Related Products in vertical
red-whiteline

RECENT VIEWED REPORTS



Sign up for newsletter

Close
Apply For Job

  • Applicant Name
  • Job Function
  • Total Experience
  • Skills
  • Email ID
  • Notice Period
  • Current CTC & Expected CTC
  • Phone Number
  • Validation
  • captcha  info-icon

    If validation code does not match, please refresh the page.

  • "Your resume has been successfully received. HR will connect you within 14 days in case your resume gets shortlisted."
Close
Download Company Brochure

  • Name
  • Email
  • Company Name
  • Select Country*
  • Phone Number
  • Validation
  •   info-icon

    If validation code does not match, please refresh the page.

Close
Engage With Us

  • Name
  • Designation
  • Email
  • Phone No.
  • Company Name
  • Company URL
  • Select Country*
  • Requirements/ Comments
  • Validation
  • captcha  info-icon

    If validation code does not match, please refresh the page.

  • "Thanks for submitting the form. The concerned team will respond to your query in the next 8-12 hours"
Close

Compare

Expand

person